Skip to main content
Erschienen in: Oral and Maxillofacial Surgery 4/2010

01.12.2010 | Case Report

A strategy to avoid facial mutilation in orbital embryonal rhabdomyosarcoma

Erschienen in: Oral and Maxillofacial Surgery | Ausgabe 4/2010

Einloggen, um Zugang zu erhalten

Abstract

Introduction

An orbital embryonal rhabdomyosarcoma (RMS) is a rare malignancy in children, but clinical findings are typical. We detail the case of an 8-year-old female with orbital RMS and discuss the therapeutic options.

Case report

Orbital RMS was apparent with painless exophthalmos of the right globe and diplopia. Head MRI showed tumor masses behind and inferior to the globe. Open biopsy led to the histological diagnosis. Metastasis or infiltration of orbital bone was not observed. Chemotherapy was carried out in accordance with the Cooperative Weichteilsarkom Studie (CWS) 2002 protocol. Tumor regression was detected after the first course of chemotherapy; we decided to excise the residual tumor with preservation of the globe. The CWS 2002 protocol was subsequently completed. Radiotherapy was not done. One year after treatment, RMS recurrence was not observed.

Conclusion

After interdisciplinary treatment, mutilation was avoided after exenteration of the orbit or radiation treatment to the growing facial skeleton. That was possible due to excision of the residual tumor in a second step, leading to down-staging of the RMS.
Literatur
1.
Zurück zum Zitat Crist W, Gehan EA, Ragab AH et al (1995) The third intergroup rhabdomyosarcoma study. J Clin Oncol 13:610–630PubMed Crist W, Gehan EA, Ragab AH et al (1995) The third intergroup rhabdomyosarcoma study. J Clin Oncol 13:610–630PubMed
2.
Zurück zum Zitat Koscielniak E, Harms D, Henze G, Jurgens H, Gadner H, Herbst M, Klingebiel T, Schmidt BF, Morgan M, Knietig R, Treuner J (1999) Results of treatment for soft tissue sarcoma in childhood and adolescence: a final report of the German cooperative soft tissue sarcoma study CWS-86. J Clin Oncol 17:3706–3719PubMed Koscielniak E, Harms D, Henze G, Jurgens H, Gadner H, Herbst M, Klingebiel T, Schmidt BF, Morgan M, Knietig R, Treuner J (1999) Results of treatment for soft tissue sarcoma in childhood and adolescence: a final report of the German cooperative soft tissue sarcoma study CWS-86. J Clin Oncol 17:3706–3719PubMed
3.
Zurück zum Zitat Maurer HM, Gehan EA, Beltangady M et al (1993) The intergroup rhabdomyosarcoma study-II. Cancer 71:1904–1922CrossRefPubMed Maurer HM, Gehan EA, Beltangady M et al (1993) The intergroup rhabdomyosarcoma study-II. Cancer 71:1904–1922CrossRefPubMed
4.
Zurück zum Zitat Taulli R, Scuoppo C, Bersani F et al (2006) Validation of met as a therapeutic target in alveolar and embryonal rhabdomyosarcoma. Cancer Res 66:4742–4749CrossRefPubMed Taulli R, Scuoppo C, Bersani F et al (2006) Validation of met as a therapeutic target in alveolar and embryonal rhabdomyosarcoma. Cancer Res 66:4742–4749CrossRefPubMed
5.
Zurück zum Zitat Frezzotti R, Hadjistilianou T, Tosi P (1990) Rhabdomyosarcoma of the orbit: clinical and histopathological analysis of a personal series of 19 cases. Orbit 9:307–312CrossRef Frezzotti R, Hadjistilianou T, Tosi P (1990) Rhabdomyosarcoma of the orbit: clinical and histopathological analysis of a personal series of 19 cases. Orbit 9:307–312CrossRef
6.
Zurück zum Zitat Fatusi OA, Ajike SO, Olateju SO et al (2009) Clinico-epidemiological analysis of orofacial rhabdomyosarcoma in a Nigerian population. Int J oral Maxillofac Surg 38:256–260CrossRefPubMed Fatusi OA, Ajike SO, Olateju SO et al (2009) Clinico-epidemiological analysis of orofacial rhabdomyosarcoma in a Nigerian population. Int J oral Maxillofac Surg 38:256–260CrossRefPubMed
7.
Zurück zum Zitat Merlino G, Helman LJ (1999) Rhabdomyosarcoma-working out the pathways. Oncogene 18:5340–5348CrossRefPubMed Merlino G, Helman LJ (1999) Rhabdomyosarcoma-working out the pathways. Oncogene 18:5340–5348CrossRefPubMed
8.
Zurück zum Zitat Newton WA Jr, Gehan EA, Webber BL et al (1995) Classification of rhabdomyosarcomas and related sarcomas. Cancer 76:1073–1085CrossRefPubMed Newton WA Jr, Gehan EA, Webber BL et al (1995) Classification of rhabdomyosarcomas and related sarcomas. Cancer 76:1073–1085CrossRefPubMed
9.
Zurück zum Zitat Warner MA, Weber AL, Jakobiec FA (1996) Benign and malignant tumors of the orbital cavity including the lacrimal gland. Neuroimaging Clin N Am 6:123–142PubMed Warner MA, Weber AL, Jakobiec FA (1996) Benign and malignant tumors of the orbital cavity including the lacrimal gland. Neuroimaging Clin N Am 6:123–142PubMed
10.
Zurück zum Zitat Daya H, Chan HSL, Sirkin W, Forte V (2000) Pediatric rhabdomyosarcoma of the head and neck. Is there a place for surgical management? Arch Otolaryngol Head Neck Surg 126:468–472PubMed Daya H, Chan HSL, Sirkin W, Forte V (2000) Pediatric rhabdomyosarcoma of the head and neck. Is there a place for surgical management? Arch Otolaryngol Head Neck Surg 126:468–472PubMed
11.
Zurück zum Zitat Shapiro DN, Sublett JE, Li B et al (1993) Fusion of PAX3 to a member of the forkhead family of transcription factors in human alveolar rhabdomyosarcoma. Cancer Res 53:5108–5112PubMed Shapiro DN, Sublett JE, Li B et al (1993) Fusion of PAX3 to a member of the forkhead family of transcription factors in human alveolar rhabdomyosarcoma. Cancer Res 53:5108–5112PubMed
12.
Zurück zum Zitat Karcioglu ZA, Hadjistilianou D, Rozans M, DeFrancesco S (2004) Orbital rhabdomyosarcoma. Cancer Control 11:328–333PubMed Karcioglu ZA, Hadjistilianou D, Rozans M, DeFrancesco S (2004) Orbital rhabdomyosarcoma. Cancer Control 11:328–333PubMed
13.
Zurück zum Zitat Oberlin O, Rey A, Anderson J et al (2001) Treatment of orbital rhabdomyosarcoma: survival and late effects of treatment–results of an international workshop. J Clin Oncol 19:197–204PubMed Oberlin O, Rey A, Anderson J et al (2001) Treatment of orbital rhabdomyosarcoma: survival and late effects of treatment–results of an international workshop. J Clin Oncol 19:197–204PubMed
14.
Zurück zum Zitat Meza JL, Anderson J, Pappo AS, Meyer WH (2006) Analysis of prognostic factors in patients with nonmetastatic rhabdomyosarcoma treated on intergroup rhabdomyosarcoma studies III and IV: the children's oncology group. J Clin Oncol 24:3844–3851CrossRefPubMed Meza JL, Anderson J, Pappo AS, Meyer WH (2006) Analysis of prognostic factors in patients with nonmetastatic rhabdomyosarcoma treated on intergroup rhabdomyosarcoma studies III and IV: the children's oncology group. J Clin Oncol 24:3844–3851CrossRefPubMed
15.
Zurück zum Zitat Cassady JR (1995) How much is enough? The continuing evolution of therapy in childhood rhabdomyosarcoma and its refinement. Int J Radiat Oncol Biol Phys 31:675–676CrossRefPubMed Cassady JR (1995) How much is enough? The continuing evolution of therapy in childhood rhabdomyosarcoma and its refinement. Int J Radiat Oncol Biol Phys 31:675–676CrossRefPubMed
16.
Zurück zum Zitat Shields CL, Shields JA, Honavar SG, Demirci H (2001) Clinical spectrum of primary ophthalmic rhabdomyosarcoma. Ophthalmology 108:2284–2292CrossRefPubMed Shields CL, Shields JA, Honavar SG, Demirci H (2001) Clinical spectrum of primary ophthalmic rhabdomyosarcoma. Ophthalmology 108:2284–2292CrossRefPubMed
17.
Zurück zum Zitat Cota N, Chandna A, Abernethy LJ (2000) Orbital abscess masquerading as a rhabdomyosarcoma. J AAPOS 4:318–320CrossRefPubMed Cota N, Chandna A, Abernethy LJ (2000) Orbital abscess masquerading as a rhabdomyosarcoma. J AAPOS 4:318–320CrossRefPubMed
18.
Zurück zum Zitat Mafee MF, Pai E, Philip B (1998) Rhabdomyosarcoma of the orbit: evaluation with MR imaging and CT. Radiol Clin North Am 36:1215–1227CrossRefPubMed Mafee MF, Pai E, Philip B (1998) Rhabdomyosarcoma of the orbit: evaluation with MR imaging and CT. Radiol Clin North Am 36:1215–1227CrossRefPubMed
19.
Zurück zum Zitat Jones IS, Reese AB, Krout J (1965) Orbital rhabdomyosarcoma: an analysis of sixty-two cases. Trans Am Ophthamol Soc 63:223–255 Jones IS, Reese AB, Krout J (1965) Orbital rhabdomyosarcoma: an analysis of sixty-two cases. Trans Am Ophthamol Soc 63:223–255
20.
Zurück zum Zitat Frayer WC, Enterline HT (1959) Embryonal rhabdomyosarcoma of the orbit in children and young adults. Arch Ophthalmol 62:203–210 Frayer WC, Enterline HT (1959) Embryonal rhabdomyosarcoma of the orbit in children and young adults. Arch Ophthalmol 62:203–210
21.
Zurück zum Zitat Jereb B, Haik BG (1985) Parameningeal rhabdomyosarcoma (including the orbit): results of orbital irradiation. Int J Radiat Oncol Biol Phys 11:2057–2065CrossRefPubMed Jereb B, Haik BG (1985) Parameningeal rhabdomyosarcoma (including the orbit): results of orbital irradiation. Int J Radiat Oncol Biol Phys 11:2057–2065CrossRefPubMed
22.
Zurück zum Zitat Shields JA, Shields CL (2003) Rhabdomyosarcoma: review for the ophthalmologist. Surv Ophthalmol 48:39–57CrossRefPubMed Shields JA, Shields CL (2003) Rhabdomyosarcoma: review for the ophthalmologist. Surv Ophthalmol 48:39–57CrossRefPubMed
23.
Zurück zum Zitat Raney RB, Anderson JR, Barr FG et al (2001) Rhabdomyosarcoma and undifferentiated sarcoma in the first two decades of life: a selective review of intergroup rhabdomyosarcoma study group experience and rationale for intergroup rhabdomyosarcoma study V. J Pediatr Hematol Oncol 23:215–220CrossRefPubMed Raney RB, Anderson JR, Barr FG et al (2001) Rhabdomyosarcoma and undifferentiated sarcoma in the first two decades of life: a selective review of intergroup rhabdomyosarcoma study group experience and rationale for intergroup rhabdomyosarcoma study V. J Pediatr Hematol Oncol 23:215–220CrossRefPubMed
24.
Zurück zum Zitat Breneman JC, Wiener ES (2000) Issues in the local control of rhabdomyosarcoma. Med Pediatr Oncol 35:104–109CrossRefPubMed Breneman JC, Wiener ES (2000) Issues in the local control of rhabdomyosarcoma. Med Pediatr Oncol 35:104–109CrossRefPubMed
Metadaten
Titel
A strategy to avoid facial mutilation in orbital embryonal rhabdomyosarcoma
Publikationsdatum
01.12.2010
Erschienen in
Oral and Maxillofacial Surgery / Ausgabe 4/2010
Print ISSN: 1865-1550
Elektronische ISSN: 1865-1569
DOI
https://doi.org/10.1007/s10006-009-0197-x

Weitere Artikel der Ausgabe 4/2010

Oral and Maxillofacial Surgery 4/2010 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.